Fluvastatin sodium anti-isomer(93957-58-5)
- Name: Fluvastatin sodium anti-isomer
- Synonyms:Fluvastatin sodium anti-isomer;93957-58-5;UNII-FRP6Z03X99;FRP6Z03X99;rel-(3R,5R)-Fluvastatin Sodium;Sodium;(E,3R,5R)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoate;DTXSID10239940;sodium (3R,5R,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoate;EN300-21908518;Q27278152;(3R,5R,6E)-3,5-Dihydroxy-7-[1-isopropyl-3-(4-fluorophenyl)-1H-indol-2-yl]-6-heptenoic acid sodium salt;(R*,R*-E)-(+/-)-7-(3-(4-FLUOROPHENYL)-1-(METHYLETHYL)-1H-INDOL-2-YL)-3,5-DIHYDROXY-6-HEPTENOIC ACID MONOSODIUM SALT;194934-99-1;6-HEPTENOIC ACID, 7-(3-(4-FLUOROPHENYL)-1-(1-METHYLETHYL)-1H-INDOL-2-YL)-3,5-DIHYDROXY-, MONOSODIUM SALT, (R*,R*-(E))-;6-HEPTENOIC ACID, 7-(3-(4-FLUOROPHENYL)-1-(1-METHYLETHYL)-1H-INDOL-2-YL)-3,5-DIHYDROXY-, MONOSODIUM SALT, (R*,R*-(E))-(+/-)-;6-HEPTENOIC ACID, 7-(3-(4-FLUOROPHENYL)-1-(1-METHYLETHYL)-1H-INDOL-2-YL)-3,5-DIHYDROXY-, SODIUM SALT (1:1), (3R,5R,6E)-REL-
- Molecular Formula:C24H25FNNaO4
- Molecular Weight:433.4
- CAS Registry Number:93957-58-5
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.93957-58-5 Fluvastatin EP Impurity A Sodium Salt
Assay:95%+ or 98%+ Appearance:solid Package:10mg/25mg/50mg/100mg/1000mg/5000mg Storage:short-term storage normal temperature. long-term storage 2-8 鈩?nbsp;Transportation:express and sea transport and air freight Application:for drug impurities, for drug standards,for drug research and development
Min. Order:25Milligram
Supplier:Hubei Moxin Biotechnology Co., Ltd [
China (Mainland)]
Other Product
- 618109-87-8/Methyl 3-amino-3-(furan-2-yl)propanoate
- 697302-67-3/(Oxomethylideneamino)methylbenzene
- 252351-95-4/Lucidadiol
- 1049982-14-0/Ethyl 1-(2-bromoethyl)-4-piperidinecarboxylate
- 933692-43-4/1-(Piperidin-3-YL)pyrrolidin-2-one
- 53460-74-5/1-Amino-3-fluoropropan-2-ol hydrochloride
- 1353965-30-6/3-Chloro-piperidine-1-carboxylic acid benzyl ester
- 1373232-29-1/(R)-1,3-Dimethyl-piperazin-2-one hydrochloride
- 1596348-16-1/2-(((2-((2-(Dimethylamino)ethyl)(ethyl)amino)-2-oxoethyl)amino)methyl)isonicotinic acid
- 1150617-88-1/1-(Quinazolin-6-yl)ethanol
- 6533-26-2/3-(6-methoxyspiro[2,4-dihydro-1H-naphthalene-3,4'-piperidine]-1'-yl)-N,N-dimethylpropan-1-amine;hydrochloride
- 97928-19-3/1-[4-(tert-Butyl)phenyl]-4-(4-hydroxypiperidin-1-yl)butan-1-one fumarate
- 54657-44-2/5,5-bis(trifluoromethyl)-3,4-dihydro-2H-furan-3-ide;carbon monoxide;cyclopenta-1,3-diene;iron(6+)
- 1632286-05-5/N-(3-Chloro-4-fluorophenyl)-N-(7-fluoro-6-nitroquinazolin-4-yl)acetamide
- 1600511-85-0/7-Methoxypyrido[3,2-d]pyrimidin-4(3H)-one
- 1638767-63-1/tert-Butyl 3-ethyl-3-ethynylazetidine-1-carboxylate
- 1833-07-4/7-Iodopyrido[1,2-b]isoquinolin-5-ium perchlorate
- 1119450-23-5/2-bromo-N-butyl-N-methylbutanamide
- 5336-85-6/9-[[3-(Dipentylamino)propyl]amino]-1,3,4-tetrahydro-7-methoxyacridine, phosphate
- 93957-58-5/Fluvastatin sodium anti-isomer
- 1567-42-6/2,4,6-Trinitrophenol--2,3-dimethylquinoline (1/1)
- 1256826-16-0/5-Chloro-4-(trifluoromethyl)nicotinaldehyde
- 1220018-16-5/4-(Piperidine-4-carbonyl)piperazin-2-one hydrochloride
- 88893-88-3/Benzo[c]phenanthren-5-amine--hydrogen chloride (1/1)
- 187540-01-8/Isoterbinafine, (E)-
- 1476727-50-0/N-{(1s)-1-[3-Fluoro-4-(Trifluoromethoxy)phenyl]-2-Methoxyethyl}-7-Methoxy-2-Oxo-2,3-Dihydropyrido[2,3-B]pyrazine-4(1h)-Carboxamide
- 1638744-45-2/(S)-4-(2-Hydroxy-3-((2-(morpholine-4-carboxamido)ethyl)amino)propoxy)phenyl 2,2-dimethylhexanoate
- 889939-86-0/2-(4-Methoxy-phenyl)-2-(4-methyl-piperidin-1-YL)-ethylamine
- 210363-27-2/(t-Butylimido)tris(diethylamino)niobium
- 1352397-13-7/7-Chloro-3-methylimidazo[1,2-a]pyridine-2-carboxylic acid ethyl ester